Medical Innovation News 27 June 2025

Roche’s $3.5B Bet on 89bio (ETNB) – Stock Soars to New Highs as NASH Breakthrough Looms

Recent Developments and News (Nov 2025) 89bio has dominated biotech headlines in late 2025 due to Roche’s takeover move. On October 30, 2025, Roche announced it had successfully completed a tender offer for 89bio at $14.50/share + a $6.00 CVR, and would

5 November 2025

Femasys (FEMY) Skyrockets on Breakthrough Birth Control Trial News – Is This Women’s Health Innovator a Game-Changer?

Company Overview – Innovating in Women’s Health Femasys Inc. is a Georgia-based medical device and biotherapeutics company specializing in women’s reproductive health solutions. Founded and led by CEO Kathy Lee-Sepsick (a female inventor-entrepreneur), Femasys aims to “transform women’s healthcare” by

3 November 2025

Birth Control · Clinical Trials · Healthcare News · Medical Innovation · NASDAQ:FEMY · Women's Health

Iovance Biotherapeutics (IOVA): TIL Cancer Breakthrough or Biotech Bust?

Company Overview: Pioneering TIL Therapy in Oncology Iovance Biotherapeutics is focused on developing tumor-infiltrating lymphocyte (TIL) therapies – a novel form of immunotherapy where a patient’s own T cells, harvested from their tumor, are expanded and activated in a lab,

3 November 2025

Biotech · Cancer Research · Immunotherapy · Medical Innovation · NASDAQ:IOVA · Stock Analysis

Off-the-Shelf CAR-T Triumph: Caribou’s Breakthrough Results Spark Stock Surge

Caribou’s Game-Changing CAR-T Results Caribou Biosciences – a clinical-stage biotech focusing on genome-edited cell therapies – stunned the biotech world with new data on November 3, 2025, showcasing that its off-the-shelf CAR-T cell treatments can achieve remission rates on par

3 November 2025

Biotechnology · Business News · Cancer Treatment · Medical Innovation · NASDAQ:CRBU · Stock Market

Evaxion (NASDAQ:EVAX) Stock Rockets After AI-Powered Cancer Vaccine Breakthrough

Evaxion’s stock jump in mid-October comes as the company lines up important clinical updates and validates its AI-driven vaccine technology. On Oct 13, Evaxion announced it will present two-year data from its Phase 2 trial of EVX-01 (a personalized cancer vaccine

15 October 2025

Artificial Intelligence · Biotechnology · Cancer Research · Medical Innovation · NASDAQ:EVAX · Stock Market

Novo Nordisk’s $5.2 Billion Bet to Reverse Fatty Liver Disease – Game-Changer or Big Gamble?

Forecast: Experts believe that within the next 2–3 years, we’ll know if Novo’s gamble pays off. Phase 3 readouts for efruxifermin are anticipated in 2026, and Novo hopes to launch the drug by late this decade if approved reuters.com. By then, the landscape

9 October 2025

Drug Development · Healthcare Industry · Liver Health · Medical Innovation · NASDAQ:AKRO · NYSE:NVO · Pharmaceuticals

From “Smart” Healing Gel to Alpha Centauri’s New Planet: Science Breakthroughs You Can’t Miss (Aug 8–9, 2025)

In preclinical tests on diabetic mice, a single application of a hydrogel-based “smart” wound dressing achieved 90% wound closure in 12 days by silencing thrombospondin-1 with microRNA-loaded extracellular vesicles. The James Webb Space Telescope’s MIRI directly imaged a gas-giant planet

9 August 2025

Breakthroughs · Exoplanets · Medical Innovation · Science News · Space Discovery

Top Biotechnology and Health Tech Trends in 2025: Mid-Year Update and Forecast (Updated: June 27th, 2025)

Late 2024, the first FDA-approved CRISPR-based therapy exagamglogene autotemcel (Casgevy) reached patients, with Vertex reporting $2 million in revenue from this sickle-cell gene-editing therapy in Q3 2024. Prime Medicine’s PM359 autologous CRISPR prime-edited cell therapy for chronic granulomatous disease began

27 June 2025

2025 Trends · Biotechnology · Forecast · Health Tech · Medical Innovation · NASDAQ:ABEO · NASDAQ:ITCI · NASDAQ:PRME · NASDAQ:RARE · NASDAQ:RGLS · NASDAQ:SWTX · NASDAQ:VRTX · NASDAQ:WVE · NYSE:AZN · NYSE:CTLT · NYSE:JNJ · NYSE:NVO · NYSE:NVS

Medical Innovation News 27 June 2025 - 5 November 2025